New Zealand pharmacists' alignment with their professional body's vision for the future

Research in Social and Administrative Pharmacy

Volumn 8, Issue 1, 2012, Pages 17-35

  Harrison, Jeff ^a   Scahill, Shane ^a   Sheridan, Janie ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Health policy; New Zealand; Pharmacists; Primary health care; Professional role

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; NEW ZEALAND; ORGANIZATION; PHARMACIST; PROFESSIONAL STANDARD; QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; ORGANIZATIONAL OBJECTIVES; PHARMACISTS; PROFESSIONAL ROLE; QUESTIONNAIRES; SOCIETIES, PHARMACEUTICAL; YOUNG ADULT;

EID: 84855843634     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2010.12.001     Document Type: Article

References (52)

1. Mesler M.A. Boundary encroachment and task delegation: clinical pharmacists on the medical team. Sociol Health Ill 1991, 13:310-331.
2. Holloway S.W.F., Jewson N.D., Mason D.J. 'Reprofessionalization' or 'occupational imperialism'?: some reflections on pharmacy in Britain. Soc Sci Med 1986, 23:323-332.
3. Birenbaum A. Reprofessionalization in pharmacy. Soc Sci Med 1982, 16:871-878.
4. The Fourth Community Pharmacy Agreement 2005, Commonwealth Government of Australia; Pharmacy Guild of Australia, Australian Government, Department of Health and Aging, Canberra (Australia), Available at:, Accessed 20.01.11. http://www.health.gov.au/internet/main/publishing.nsf/Content/F7FBDB333D030BFFCA2570C000003A44/$File/4cpacompilation.pdf.
5. Pharmacy in the future: a vision for pharmacy in the new NHS 2000, Department of Health, Department of Health, London(England).
6. Pharmacy in the future: a vision for pharmacy in the new NHS 2000, Department of Health, Department of Health, London(England).
7. Pharmacy Affairs and 340B Drug Pricing Program 2008, United States Government, US Dept of Health and Human Services, Rockville, MD.
8. The Medicare Prescription Drug, Improvement and Modernization Act of 2003 2003, Department UST, Trans.
9. Pharmacy in England: building on strengths - delivering the future 2008, Department of Health, HM Government, The Stationary Office, London(England), ISBN 9780101734127.
10. The Fifth Community Pharmacy Agreement 2010, Commonwealth Government of Australia; Pharmacy Guild of Australia, Australian Government, Department of Health and Aging, Canberra (Australia), Available at:, Accessed 20.01.11. http://www.health.gov.au/internet/main/publishing.nsf/Content/C3DB799DB360AF0CCA25772000249FA8/$File/5CPA%20Agreement%2005%20August%202010.pdf.
11. Blueprint for pharmacy: the vision for pharmacy 2008, Task Force on a Blueprint for Pharmacy, CanadianPharmacists Association, Ottawa (ON), Available at:, Accessed 20.01.11. http://www.pharmacists.ca/content/about_cpha/whats_happening/cpha_in_action/pdf/BlueprintVision.pdf.
12. Tsuyuki R., Schindel T.J. Leading Change in Pharmacy Practice: Fully Engaging Pharmacists in Patient-Oriented Healthcare 2004, COMPRIS, University of Alberta, Edmonton, Canada.
13. Anonymous A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. American College of Clinical Pharmacy. Pharmacotherapy 2000, 20:991-1020.
14. Patel H. How the Pharmacy 2020 vision is lighting the way for pharmacy's future. Pharm J 2007, 279:131-132.
15. Ministry of Health New Zealand Primary Health Care Strategy 2001, New Zealand Ministry of Health.
16. Ministry of Health Towards a Medicines Strategy 2006, Ministry of Health, Wellington, New Zealand.
17. Ministry of Health New Zealand Medicines Strategy 2007, Ministry of Health, Wellington, New Zealand.
18. Pharmacy Sector Action Group Focus on the future: ten-year vision for pharmacists in New Zealand [PortableDocument Format] Available at:, Accessed 06.12.10. http://psnz.org.nz/public/home/documents/10_yea_plan.pdf.
19. Kotter J.P. Leading change: why transformation efforts fail. Harv Bus Rev 1995, 73:59-67.
20. Managing Organisational Change 2002, John Wiley & Sons, Milton, Australia. F. Graetz, M. Rimmer, A. Lawrence, A. Smith (Eds.).
21. Scahill S., Harrison J., Sheridan J. The ABC of New Zealand's ten year vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract 2009, 17:135-142.
22. Scahill S., Harrison J., Sheridan J. Pharmacy under the spotlight: New Zealand pharmacists' perceptions of current and future roles and the need for accreditation. Int J Pharm Pract 2010, 18:59-62.
23. Teddlie C., Tashakkori A. Foundations of Mixed Methods Research: Integrating Quantitative and Qualitative Approaches in the Social and Behavioral Sciences 2009, SAGE Publications, Inc., Thousand Oaks, CA.
24. Ministry of Health, Wellington, New Zealand District Health Boards: frequently asked questions [webpage] Available at:, Accessed 04.10.10. http://www.moh.govt.nz/moh.nsf/indexmh/dhb-faq.
25. Kotter J.P., Schlesinger L.A. Choosing strategies for change. Harv Bus Rev 2008, 86:130-139.
26. Roberts A.S., Benrimoj S.I., Chen T.F., Williams K.A., Hopp T.R., Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm 2005, 1:546-564.
27. Bryant L. Evaluation of the Barriers to and Implementation of Comprehensive Pharmaceutical Care in New Zealand 2006, General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
28. Bush J., Langley C.A., Jesson J.K., Wilson K.A. Perceived barriers to the development of community pharmacy's public health function: a survey of the attitudes of directors of public health and chief pharmacists in UK primary care organisations. Int JPharm Pract 2006, 2:B68-B69.
29. Elvey R., Bradley F., Ashcroft D., Noyce P. Implementing medication usage reviews through the new community pharmacy contract: key drivers and barriers. Int J Pharm Pract 2006, 14(suppl 2):B32-B33.
30. Hall J., Smith I. Barriers to medicines use reviews: comparing the views of pharmacists and PCTs. Int J Pharm Pract 2006, 14(suppl 2):B51-B52.
31. Roberts A.S., Benrimoj S.I., Chen T.F., Williams K.A., Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract 2006, 14:163-170.
32. Hopp T.R., Sorensen E.W., Herborg H., Roberts A.S. Implementation of cognitive pharmaceutical services (CPS) in professionally active pharmacies. Int JPharm Pract 2005, 13:21-31.
33. Van Mil J.W.F., De Boer W.O., Tromp T.F.J. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001, 9:163-168.
34. Lounsbery J., Green C., Bennett M., Pedersen C.A. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. JAm Pharm Assoc (2003) 2009, 49:51-58.
35. Snyder M.E., Zillich A.J., Primack B.A., et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm 2010, 6(4):307-323.
36. McCann L., Hughes C.M., Adair C.G. A self-reported work-sampling study in community pharmacy practice: a 2009 update. Pharm World Sci 2010, 32:536-543.
37. Berbatis C.G., Sunderland V.B., Joyce A., Bulsara M., Mills C. Characteristics of Australia's community pharmacies: National Pharmacy Database Project. Int J Pharm Pract 2007, 15:265-271.
38. Schommer J.C., Pedersen C.A., Gaither C.A., Doucette W.R., Kreling D.H., Mott D.A. Pharmacists' desired and actual times in work activities: evidence of gaps from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc 2006, 46:340-347.
39. Doucette W.R., Kreling D.H., Schommer J.C., Gaither C.A., Mott D.A., Pedersen C.A. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. JAm Pharm Assoc 2006, 46:348-355.
40. Schommer J.C., Pedersen C.A., Doucette W.R., Gaither C.A., Mott D.A. Community pharmacists' work activities in the United States during 2000. JAm Pharm Assoc 2002, 42:399-406.
41. Bell H.M., McElnay J.C., Hughes C.M. A self-reported work sampling study in community pharmacy practice. Pharm World Sci 1999, 21:210-216.
42. Pronk M.C., Blom L.T., Jonkers R., Rogers E.M., Bakker A., de Blaey K.J. Patient oriented activities in Dutch community pharmacy: diffusion of innovations. Pharm World Sci 2002, 24:154-161.
43. Midwest Pharmacy Workforce Research Consortium. Final report of the 2009 National Sample Survey of the Pharmacist Workforce to Determine Contemporary Demographic and Practice Characteristics. Paper presented at: Pharmacy Manpower Project, Inc.; March 1, 2010; Alexandria, VA.
44. Martin J. Cultures in Organisations: Three Perspectives 1992, Oxford University Press, New York, NY. 1st ed.
45. Pharmacy Council of New Zealand Pharmacy Council of New Zealand Workforce Demographics Survey 2007, Pharmacy Council (NZ), Wellington, New Zealand.
46. Oppenheim A. Questionnaire Design, Interviewing and Attitude Measurement 1992, Pinter, London, UK.
47. Edmunds J., Calnan M.W. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med 2001, 53:943-955.
48. Adamcik B.A., Ransford H.E., Oppenheimer P.R., Brown J.F., Eagan P.A., Weissman F.G. New clinical roles for pharmacists: a study of role expansion. Soc Sci Med 1986, 23:1187-1200.
49. Bryant L.J.M., Coster G., Gamble G.D., McCormick R.N. General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm 2009, 5:347-362.
50. McDonald R., Cheraghi-Sohi S., Sanders C., Ashcroft D. Professional status in a changing world: the case of medicines use reviews in English community pharmacy. Soc Sci Med 2010, 71:451-458.
51. Scott A., Bond C., Inch J., Grant A. Preferences of community pharmacists for extended roles in primary care-a survey and discrete choice experiment. Pharmacoeconomics 2007, 25:783-792.
52. Cooksey J.A., Knapp K.K., Walton S.M., Cultice J.M. Challenges to the pharmacist profession from escalating pharmaceutical demand. Health Aff 2002, 21:182-188.